CN102441110A - Traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism - Google Patents

Traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism Download PDF

Info

Publication number
CN102441110A
CN102441110A CN2011103921476A CN201110392147A CN102441110A CN 102441110 A CN102441110 A CN 102441110A CN 2011103921476 A CN2011103921476 A CN 2011103921476A CN 201110392147 A CN201110392147 A CN 201110392147A CN 102441110 A CN102441110 A CN 102441110A
Authority
CN
China
Prior art keywords
parts
radix
hyperthyroidism
rhizoma
auxiliary treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011103921476A
Other languages
Chinese (zh)
Other versions
CN102441110B (en
Inventor
李金金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong Hongci Pharmaceutical Co Ltd
Original Assignee
李金金
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 李金金 filed Critical 李金金
Priority to CN 201110392147 priority Critical patent/CN102441110B/en
Publication of CN102441110A publication Critical patent/CN102441110A/en
Application granted granted Critical
Publication of CN102441110B publication Critical patent/CN102441110B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism. The traditional Chinese medicinal composition comprises the following components of: by weight, 3-5 parts of Chinese magnoliavine, 2-4 parts of polygonatum rhizome, 3-4 parts of Radix Astragali, 10-13 parts of radix bupleuri, 3-6 parts of pasque flower, 2-5 parts of oriental waterplantain rhizome, 6-8 parts of oyster, 1-2 parts of prunella vulgaris, 2-6 parts of asparagi radix, 2-4 parts of Zhejiang fritillaria bulb, 4-7 parts of dark plum, 4-6 parts of viola yedoensis makino, 1-2 parts of fleece-flower root, 4-6 parts of calyxkaki persimmon calyx, and 1-2 parts of anemarrhena. With reasonable selection of the Chinese herbal medicines, the prescription has characteristics of mitigating the symptom of hyperthyroidism patients and reducing side-effects of western medicines.

Description

A kind of Chinese medicine composition of auxiliary treatment hyperthyroidism
Technical field
The present invention relates to a kind of Chinese medicine composition, more particularly a kind of Chinese medicine composition with effect of auxiliary treatment hyperthyroidism.
Background technology
Hyperthyroidism is called for short hyperthyroidism, and its clinical manifestation is that thyroid function strengthens, and secretion thyroxin (TH) is too much, causes system's irritabilitys such as nerve, circulation and digestion of body to increase and hypermetabolism.
Because thyroxin is too much, acts on each internal organs of whole body, thereby the symptom that occurs is varied.The women is more common in hyperthyroidism, and men and women's ratio is 1: 4~1: 6, the age each the group all can fall ill, with 20~40 years old for seeing more.Onset is generally slow, and majority is not sure of time, and minority is at direct stimulation or infect the back onset, and the clinical manifestation weight differs.When typical case performance, it is all more obvious that hypermetabolism disease crowd, goiter and eye are levied the performance of three aspects, but gentlier can obscure mutually with neurosis like the state of an illness, the patient who has can certain (a bit) characteristic symptom such as expophthalmos, cachexia or myopathy etc. for mainly showing.The performance of old people and child patient often is not true to type.In recent years, because diagnostic level progressively improves, the light disease and the patient's that is not true to type discovery day by day increases.
The Western medicine commonly used of treatment hyperthyroidism at present has methimazole, levothyroxine, propylthiouracil, these medicines intravital thyroid content of balance as soon as possible; But they have side effect; Such as pruritus, erythra, fever, inflammation and leukopenia; In case do not take these medicines, tend to recurrence.
The traditional Chinese medical science belongs to primary disease " goiter " category, and the traditional Chinese medical science thinks because seven emotions are unsuccessful, depression of liver-QI, stagnated QI transforming into fire, on attack in head, so the hyperthyroid patient being irritable and getting angry easily, flushing conjunctival congestion, bitter taste in the mouth and dry throat is had a dizzy spell; Pathogenic fire derived from stagnation of liver-QI, the stomach-Yin of burning, so excessiveness of stomach-fire is rapid digestion of food and polyorexia; Deficiency-weakness of spleen-QI, failure of the spleen to transport and transform, it is weak then to become thin; Stagnation of QI due to depression of the liver influences chong channel, thus menoxenia, infrequent menstruation, amenorrhea; Deficiency of kidney yin, hyperactivity of the ministerial fire, then man's seminal emission, sexual impotence; Deficiency of kidney yin, the kidney failing to nourish the liver, excessive rising of liver-YANG then, hands tremor linguae; Heart deficiency of the kidney yin, then nervous, cardiopalmus, insomnia and dreamful sleep, hyperhidrosis; Interior-heat caused by deficiency of YIN, then To Be Protected from Heat, red tongue, thready and rapid pulse.The plain body deficiency of YIN of patient meets the stagnation of QI, then is prone to fire-transformation, the cloudy blood of burning.In a word, patient's stagnated QI transforming into fire, refining liquid is expectorant, mental disorder is handed over and is hindered in the throat, then sends out in wart swollen; Mental disorder is condensed in order, then exophthalmos.
Therefore, I invent multi a kind of when taking Western medicine, the Chinese medicine composition of auxiliary treatment hyperthyroidism has the side effect that alleviates Western medicine, improves the effect of therapeutic effect.
Summary of the invention
The present invention provides a kind of Chinese medicine composition of auxiliary treatment hyperthyroidism, rationally selects Chinese herbal medicine for use, has the hyperthyroid patient of alleviating symptom, reduces the characteristics of Western medicine side effect.
The present invention adopts following technical scheme to realize:
A kind of Chinese medicine composition of auxiliary treatment hyperthyroidism is characterized in that, employing is the component by following parts by weight: Fructus Schisandrae Chinensis 3-5 part, Rhizoma Polygonati 2-4 part, Radix Astragali 3-4 part; Radix Bupleuri 10-13 part, Radix Pulsatillae 3-6 part, Rhizoma Alismatis 2-5 part, Concha Ostreae 6-8 part; Spica Prunellae 1-2 part, Radix Asparagi 2-6 part, Bulbus Fritillariae Thunbergii 2-4 part, Fructus Mume 4-7 part; Herba Violae 4-6 part, Radix Polygoni Multiflori 1-2 part, Calyx Kaki 4-6 part, Rhizoma Anemarrhenae 1-2 part.
Further, technical scheme of the present invention is: a kind of Chinese medicine composition of auxiliary treatment hyperthyroidism is characterized in that employing is the component by following parts by weight: 4 parts of Fructus Schisandrae Chinensis, 3 parts of Rhizoma Polygonatis; 4 parts of the Radixs Astragali, 12 parts of Radix Bupleuri, 4 parts of the Radix Pulsatillaes, 3 parts of Rhizoma Alismatis, 7 parts of Concha Ostreaes; 1 part of Spica Prunellae, 5 parts of Radix Asparagis, 3 parts of Bulbus Fritillariae Thunbergiis, 6 parts of Fructus Mumes; 5 parts of Herba Violaes, 1 part of Radix Polygoni Multiflori, 5 parts of Calyx Kaki, 2 parts of the Rhizoma Anemarrhenaes.
Preparation and instructions of taking: the Impurity removal with each crude drug is decocted in water for oral dose potion on the one.Ten days is a course of treatment.
The specific embodiment
Embodiment one
Get Fructus Schisandrae Chinensis 3g, Rhizoma Polygonati 2g, Radix Astragali 3g, Radix Bupleuri 10g, Radix Pulsatillae 3g, Rhizoma Alismatis 2g, Concha Ostreae 6g, Spica Prunellae 1g, Radix Asparagi 2g, Bulbus Fritillariae Thunbergii 2g, Fructus Mume 4g, Herba Violae 4g, Radix Polygoni Multiflori 1g, Calyx Kaki 4g, Rhizoma Anemarrhenae 1g, the Impurity removal with each crude drug is decocted in water for oral dose.
Embodiment two
Get Fructus Schisandrae Chinensis 5g, Rhizoma Polygonati 4g, Radix Astragali 4g, Radix Bupleuri 13g, Radix Pulsatillae 6g, Rhizoma Alismatis 5g, Concha Ostreae 8g, Spica Prunellae 2g, Radix Asparagi 6g, Bulbus Fritillariae Thunbergii 4g, Fructus Mume 7g, Herba Violae 6g, Radix Polygoni Multiflori 2g, Calyx Kaki 6g, Rhizoma Anemarrhenae 2g, the Impurity removal with each crude drug is decocted in water for oral dose.
Embodiment three
Fructus Schisandrae Chinensis 4g, Rhizoma Polygonati 3g, Radix Astragali 4g, Radix Bupleuri 12g, Radix Pulsatillae 4g, Rhizoma Alismatis 3g, Concha Ostreae 7g, Spica Prunellae 1g, Radix Asparagi 5g, Bulbus Fritillariae Thunbergii 3g, Fructus Mume 6g, Herba Violae 5g, Radix Polygoni Multiflori 1g, Calyx Kaki 5g, Rhizoma Anemarrhenae 2g, the Impurity removal with each crude drug is decocted in water for oral dose.
Therapeutic effect
Case one:
Liu xx, the woman, 51 years old, suffer from hyperthyroidism more than 5 years, the whole body dysphoria with smothery sensation, 37.5~38 ℃ of body temperature are observed patient and are become thin obviously when examining, slight eye is dashed forward, it is more to perspire, with hand tremor, take this prescription after, sx.
Case two:
Hao, man, 31 years old; Nervous, symptom such as both hands tremble, appetite increases severely, defecate frequently, day by day become thin at midnight appears over nearly one month, after chemically examining to hospital, and demonstration T3; T4 is higher; After taking Western medicine, cooperate take this prescription after two courses of treatment all symptoms disappear basically, continue to fully recover after two courses of treatment of treatment.

Claims (2)

1. the Chinese medicine composition of an auxiliary treatment hyperthyroidism is characterized in that, employing is the component by following parts by weight: Fructus Schisandrae Chinensis 3-5 part, Rhizoma Polygonati 2-4 part, Radix Astragali 3-4 part; Radix Bupleuri 10-13 part, Radix Pulsatillae 3-6 part, Rhizoma Alismatis 2-5 part, Concha Ostreae 6-8 part; Spica Prunellae 1-2 part, Radix Asparagi 2-6 part, Bulbus Fritillariae Thunbergii 2-4 part, Fructus Mume 4-7 part; Herba Violae 4-6 part, Radix Polygoni Multiflori 1-2 part, Calyx Kaki 4-6 part, Rhizoma Anemarrhenae 1-2 part.
2. the Chinese medicine composition of a kind of auxiliary treatment hyperthyroidism as claimed in claim 1 is characterized in that: fractional each component of wherein wt is following: 4 parts of Fructus Schisandrae Chinensis, 3 parts of Rhizoma Polygonatis, 4 parts of the Radixs Astragali; 12 parts of Radix Bupleuri, 4 parts of the Radix Pulsatillaes, 3 parts of Rhizoma Alismatis, 7 parts of Concha Ostreaes; 1 part of Spica Prunellae, 5 parts of Radix Asparagis, 3 parts of Bulbus Fritillariae Thunbergiis, 6 parts of Fructus Mumes; 5 parts of Herba Violaes, 1 part of Radix Polygoni Multiflori, 5 parts of Calyx Kaki, 2 parts of the Rhizoma Anemarrhenaes.
CN 201110392147 2011-12-01 2011-12-01 Traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism Active CN102441110B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110392147 CN102441110B (en) 2011-12-01 2011-12-01 Traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110392147 CN102441110B (en) 2011-12-01 2011-12-01 Traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism

Publications (2)

Publication Number Publication Date
CN102441110A true CN102441110A (en) 2012-05-09
CN102441110B CN102441110B (en) 2013-08-21

Family

ID=46004370

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110392147 Active CN102441110B (en) 2011-12-01 2011-12-01 Traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism

Country Status (1)

Country Link
CN (1) CN102441110B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105853567A (en) * 2016-03-22 2016-08-17 中国中医科学院中医临床基础医学研究所 Traditional Chinese medicine composition for treating hyperthyroidism and preparation method thereof
CN108853331A (en) * 2017-05-08 2018-11-23 张震 A kind of Chinese medicine composition and preparation method thereof for treating hyperthyroidism

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1485083A (en) * 2003-06-13 2004-03-31 许新琳 Capsule for thyroid cancer / tumor and lymph node
CN101085207A (en) * 2007-06-26 2007-12-12 北京艺信堂医药研究所 Traditional Chinese medicine preparation for treating hyperthyroidism
CN101152535A (en) * 2007-09-15 2008-04-02 尹克华 Traditional Chinese medicine for treating subacute thyroiditis
CN101152511A (en) * 2007-09-17 2008-04-02 李广欣 Medicament for treating hyperthyroidism disease and method of preparing the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1485083A (en) * 2003-06-13 2004-03-31 许新琳 Capsule for thyroid cancer / tumor and lymph node
CN101085207A (en) * 2007-06-26 2007-12-12 北京艺信堂医药研究所 Traditional Chinese medicine preparation for treating hyperthyroidism
CN101152535A (en) * 2007-09-15 2008-04-02 尹克华 Traditional Chinese medicine for treating subacute thyroiditis
CN101152511A (en) * 2007-09-17 2008-04-02 李广欣 Medicament for treating hyperthyroidism disease and method of preparing the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
徐申元: "肉瘿治验", 《实用乡村医生杂志》 *
李永康: "甲状腺腺瘤(肉瘤)", 《浙江中医药大学学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105853567A (en) * 2016-03-22 2016-08-17 中国中医科学院中医临床基础医学研究所 Traditional Chinese medicine composition for treating hyperthyroidism and preparation method thereof
CN108853331A (en) * 2017-05-08 2018-11-23 张震 A kind of Chinese medicine composition and preparation method thereof for treating hyperthyroidism

Also Published As

Publication number Publication date
CN102441110B (en) 2013-08-21

Similar Documents

Publication Publication Date Title
CN102302563A (en) Chinese medicinal composition for treating chronic kidney failure and preparation method thereof
CN103223118B (en) Traditional Chinese medicine composition for treating facial paralysis
CN103432559B (en) Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof
CN103520395A (en) Traditional Chinese medicine composition for treating lung cancer
CN102441110B (en) Traditional Chinese medicinal composition for auxiliary treatment of hyperthyroidism
CN102430105B (en) Traditional Chinese medicine composite for treating chronic gastritis
CN103977281A (en) Traditional Chinese medicine composition for treating female endocrine disorders and preparation method thereof
CN103041213A (en) Traditional Chinese medicine composition for soothing nerves, calming and relieving depression
CN102988892B (en) Medicament for treating hysteromyoma and ovarian cysts
CN103656453A (en) Semen litchi stomach-nourishing condensed pill and preparation method thereof
CN103566190A (en) Traditional Chinese medicine composition for treating epigastric pain
CN103272159A (en) Chinese herbal preparation used for treating consumptive disease and preparation method thereof
CN103393825A (en) Traditional Chinese medicine for treating catatonic headache and preparation method thereof
CN102441109B (en) Traditional Chinese medicinal composition for adjuvant treatment of hyperthyroidism
CN101664488B (en) Traditional Chinese medicine for treating infant eczema
CN103751357A (en) Traditional Chinese medicine composition for treating spleen-deficiency-type colonitis
CN104547709A (en) Chinese medicinal composition for treating meniere disease as well as preparation method and application thereof
CN103816446A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN103550541A (en) Traditional Chinese medicine composition for treating chronic hepatitis
CN103520354A (en) Traditional Chinese medicine for treatment of blood-insufficiency type mammary gland hyperplasia and preparation method thereof
CN103494939A (en) Traditional Chinese medicine for treating senile habitual constipation
CN103751575B (en) A kind of Chinese medicine composition treating edema disease
CN106267104A (en) A kind of decoction medicine treating depression, insomnia and neurasthenia and preparation method
CN104689109A (en) Traditional Chinese medicine decoction for treating hypertension
CN105125964A (en) Traditional Chinese medicine preparation for treating pelvic peritonitis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: 364300 Longyan City, Fujian Province Qingyun Wuping County Hill Industrial Park 8 Building No. 2

Patentee after: Li Jinjin

Address before: 315300 Zhejiang Province, Cixi city Hushanjiedao Cixi villa villa No. 37

Patentee before: Li Jinjin

ASS Succession or assignment of patent right

Owner name: NANTONG HONGCI PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: LI JINJIN

Effective date: 20140609

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 364300 LONGYAN, FUJIAN PROVINCE TO: 226200 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20140609

Address after: 226200 chemical industry park, Nantong, Qidong, Jiangsu

Patentee after: NANTONG HONGCI PHARMACEUTICAL CO., LTD.

Address before: 364300 Longyan City, Fujian Province Qingyun Wuping County Hill Industrial Park 8 Building No. 2

Patentee before: Li Jinjin